4
Changes in Ownership
Vivos Therapeutics, Inc. Filed Acc 0001493152-26-043383
Chief Executive Officer acquired 85,910 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Huntsman Ronald Kirk Chief Executive Officer | 2026-06-30 | Other acquisition | +85,910 | $0.58 | $50,000 | 85,910 | I |
| Derivatives | |||||||
| Huntsman Ronald Kirk Chief Executive Officer | 2026-06-30 | Other acquisition · Warrant (Right to Buy) | +85,910 | $0.58 | $50,000 | 85,910 | I |
Loading xslF345X06/ownership.xml…